Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TG Therapeutics Q2 2024 GAAP EPS $0.04 Beats $(0.05) Estimate, Sales $73.466M Beat $65.893M Estimate

Author: Benzinga Newsdesk | August 06, 2024 07:02am
TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.05) by 180 percent. The company reported quarterly sales of $73.466 million which beat the analyst consensus estimate of $65.893 million by 11.49 percent. This is a 357.05 percent increase over sales of $16.074 million the same period last year.

Posted In: TGTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist